AmCad BioMed Corporation (TPEX:4188)

AmCad BioMed Revenue

In the year 2025, AmCad BioMed had annual revenue of 30.44M TWD, down -42.69%. AmCad BioMed had revenue of 5.07M in the quarter ending December 31, 2025, a decrease of -72.08%.

• Revenue: 30.44M
• Revenue Growth: -42.69%
• P/S Ratio: 27.47
• Revenue / Employee: 895.21K
• Employees: 34
• Market Cap: 835.99M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	30.44M	-22.67M	-42.69%
Dec 31, 2024	53.11M	-12.15M	-18.62%
Dec 31, 2023	65.26M	3.63M	5.88%
Dec 31, 2022	61.63M	-24.16M	-28.16%
Dec 31, 2021	85.79M	21.85M	34.17%